Ismail Omran

Ismail Omran practices at Avera Dialysis - Mitchell in Mitchell, South Dakota.

Ismail Omran's NPI, 1023539590, was assigned on July 5, 2017. Ismail Omran holds New York license 00000000000000.

Ismail Omran's primary practice is Avera Dialysis - Mitchell, at 1900 Grassland Dr Ste 102, Mitchell, SD 57301 in Davison County. The practice phone is (605) 995-6730.

Ismail Omran's primary practice is Avera Dialysis - Mitchell in Mitchell, South Dakota. Ismail Omran is also affiliated with Avera Queen of Peace Hospital. The medical group on file is Edith Sanford Breast Center Sioux Falls. Dmand AI also links Ismail Omran to 5 more hospitals, 2 dialysis centers and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ismail Omran practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Ismail Omran's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Ismail Omran is licensed in New York.

CMS data shows 1,994 Medicare services from Ismail Omran across 12 procedure codes in 2024, for 576 Medicare patients. Medicare paid $161,175 for them.

CMS counts 576 Medicare patients who saw Ismail Omran in 2024. The largest group is 65 to 74, with 227 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 21% are also on Medicaid. Their average risk score is 3.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ismail Omran's median patient age at 76, with 50% women.

In 2024, Ismail Omran wrote 1,606 Medicare Part D claims for 339 patients. 92% of them were for generic drugs. CMS names the drug for 1,470 of them, across 26 drugs with 11 or more claims each, at $77,379 in total drug cost. In 2023, CMS named 267 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Ismail Omran for performance year 2024, reported through an alternative payment model (APM). Ismail Omran accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ismail Omran as offering telehealth.

Dmand AI links 3 papers to Ismail Omran, published from 2021 to 2022. Ismail Omran has published most often in Cureus. Ismail Omran's most frequent co-authors are Mariam Agladze, MD, Jonathan E. Ariyaratnam, MD and Sakil Amin Bhuiyan, MD.

CMS Open Payments shows 25 general payments to Ismail Omran from 13 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 98% of the total. Calliditas Therapeutics US Inc. paid the most, $179.